The effect of the Accu-chek Mobile blood glucose monitoring system of testing frequency in type one diabetes.

Not Applicable

• Conditions: Type 1 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12612000144819
• Lead Sponsor: Roche Diagnostics Australia Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-02-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Type 1 diabetes diagnosed for greater than or equal to one year
2. Known to the study site (ie. attended for clinical care greater than or equal to 2 visits in the last 2 years)
3. Glycosylated haemoglobin (HbA1c) greater than or equal to 7.5 %
4. Aged 18-45 years
5. Their health care professional recommends that they monitor greater than or equal to 4 times a day
5. They are performing some monitoring but less than 21 blood glucose estimations per week
6. They are able to understand, read and write English without assistance
7. They are willing to attend for all of the scheduled study visits
8. They are prepared to use the two blood glucose monitoring systems being used in the study.

Exclusion Criteria

1. Type 2 diabetes
2. Use of oral or inhaled steroids
3 They are pregnant or planning a pregnancy
4. They have an infection
5. medical condition, such as cancer, severe depression or other psychological conditions that, in the opinion of the investigators, makes the person unsuitable for inclusion in the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Average blood glucose estimations/week<br>This will be assessed by downloading the machine memory and counting the number of tests performed in the 3 month period.[0,3,6,9 months]

Secondary Outcome Measures

Name	Time	Method
Psychosocial measures<br>The Diabetes Treatment Satisfaction Questionnaire (DTSQ) Confidence in Diabetes Scale (CIDS) <br>Problem Areas in Diabetes Management (PAID) Scale<br>The modified* Blood Glucose Monitoring Questionnaire (BGM-Q) [* questions 4,15 & 16 removed].[0,3,6,9 months]